Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 14,139 |
|
|||||
| News | - | ||||||
| Day High | 1.85 | Low High |
|||||
| Day Low | 1.7701 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Silo Pharma Inc | SILO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.85 | 16:02:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.85 | 1.7701 | 1.85 | 1.85 | 1.85 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 137 | 14,139 | $ 1.80 | $ 25,439 | - | 1.2162 - 3.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 52 | $ 1.80 | USD |
Silo Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.75M | 3.11M | - | 72k | -3.7M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Silo Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SILO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.86 | 1.94 | 1.77 | 1.86 | 30,125 | -0.01 | -0.54% |
| 1 Month | 1.99 | 2.40 | 1.63 | 1.89 | 444,611 | -0.14 | -7.04% |
| 3 Months | 1.53 | 2.40 | 1.44 | 1.83 | 213,273 | 0.32 | 20.92% |
| 6 Months | 1.59 | 2.40 | 1.24 | 1.75 | 175,230 | 0.26 | 16.35% |
| 1 Year | 2.09 | 3.05 | 1.2162 | 2.02 | 198,357 | -0.24 | -11.48% |
| 3 Years | 6.60 | 7.26 | 1.2162 | 2.65 | 237,549 | -4.75 | -71.97% |
| 5 Years | 6.60 | 7.26 | 1.2162 | 2.65 | 237,549 | -4.75 | -71.97% |
Silo Pharma Description
| SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. |
